Meet Spain's biotech ecosystem at BIOSPAIN 2026 in Bilbao. Now annual, the event draws 1,000+ companies and participants from 30+ countries.

At NLS Days 2026, life science companies and a record number of investors attended to showcase data, partner, and raise ...

Explore the preclinical research catching our eye in September 2026, from siRNA and in vivo CRISPR to targeted protein ...

A lot is going on in the GLP-1 space in 2026, a market that landed $79 billion last year, and could shift significantly in the coming years.

Discover Andy Brown's long and arduous journey battling a type of non-Hodgkin lymphoma and how a clinical trial altered his ...

Take a look at the Eli Lilly pipeline in 2026 as the incretin franchise grows and fuels the rest of the company's pipeline.

Discover how early optimization in stable cell line development accelerates timelines and reduces downstream bottlenecks.

Not a lot went down on the biotech deals front in August 2026, but it did see sustained collaboration in oncology and ...

The companies Moderna, Amylyx Pharmaceuticals, and Braveheart Bio bagged the biggest biotech funding rounds overall in August ...

At the end of each year, Labiotech selects a list of biotech companies it believes are worth keeping an eye on for the coming year. In December 2023, we highlighted nine biotech companies as “ones to ...

According to the World Health Organization (WHO), breast cancer was the most common cancer in women in 157 countries out of 185 in 2022, with incidence rates found to be rising by 1% per year overall ...

See why investor confidence in cell and gene therapies now depends on execution and supply chain strategy—not strong science alone.